Q3 FY2026 · ended Jun 30, 2026 · Revenue $1.97M, +16.3% YoY · Filed Aug 13, 2026
NeuroOne Medical Technologies Corporation (NMTC) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $2.0 million and a net loss of $2.0 million. Free cash flow was -$1.1 million. As of Jun 30, 2026 it held $2.0 million in cash and investments and $175,345 in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- NMTC (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Eden Prairie, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1500198
- Former names
- Original Source Entertainment, Inc. (until May 22, 2017)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Jun 30, 2026 |
Q2 FY2026 Mar 31, 2026 |
Q1 FY2026 Dec 31, 2025 |
Q4 FY2025 Sep 30, 2025 |
Q3 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $2.0M | $1.9M | $2.9M | $2.7M | $1.7M |
| Operating income | -$2.4M | -$2.4M | -$1.7M | -$1.4M | -$1.9M |
| Net income | -$2.0M | -$2.4M | -$1.4M | -$1.6M | -$1.5M |
| Diluted EPS | -$0.28 | -$0.28 | -$0.03 | -$0.01 | -$0.19 |
| Operating cash flow | -$1.1M | -$1.3M | -$3.1M | -$1.5M | -$1.5M |
| Free cash flow | -$1.1M | -$1.4M | -$3.2M | -$1.5M | -$1.5M |
| Total assets | $6.2M | $7.6M | $8.6M | $10.8M | $10.8M |
| Total liabilities | $2.4M | $2.5M | $2.2M | $3.7M | $2.6M |
| Stockholders' equity | $3.8M | $5.1M | $6.4M | $7.1M | $8.2M |
| Cash and investments | $2.0M | $2.8M | $3.6M | $6.6M | $8.0M |
| Total debt | $175,345 | $206,973 | $237,377 | $266,806 | $295,717 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Other events
|
Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Other events
|
Aug 27, 2026 | Aug 27, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Other events
|
Jun 12, 2026 | Jun 12, 2026 |
| 10-Q/A | Amended quarterly report | Jun 12, 2026 | Mar 31, 2026 |
All 653 NeuroOne Medical Technologies Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.